Global Oral Antidiabetic Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug Class Analysis;

Sulfonylureas - Glimepiride, Gliclazide, Glyburide and Others, Meglitinides - Repaglinide and Nateglinide, Biguanides - Metformin and Others, Alpha-glucosidase inhibitors - Acarbose, Voglibose and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn804412413 Published Date: May, 2022 Updated Date: June, 2022

Introduction

Global Oral Antidiabetic Drugs Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 107.1
2019 119.8
2020 123.7
2021 143.0
2022 160.8
2023 163.4
2024 168.7
2025 171.2
2026 200.3
2027 216.5
2028 230.2

In the year 2021, the Global Oral Antidiabetic Drugs Market was valued at USD 23,402.57 million. The size of this market is expected to increase to USD 31,529.04 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class Analysis
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Oral Antidiabetic Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Global Oral Anti-Diabetic Market Drivers: Impact Analysis
        2. Rising Prevalence Of Diabetes Mellitus
        3. Increase In Obesity
      2. Restraints
        1. Global Oral Anti-Diabetic Market Restraints: Impact Analysis
        2. High Cost of Drugs
      3. Opportunities
        1. Market Strength
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Oral Antidiabetic Drugs Market,By Drug Class Analysis, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Sulfonylureas
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Glimepiride
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Gliclazide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Glyburide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            4. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Meglitinides
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Repaglinide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Nateglinide
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Biguanides
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Metformin
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Alpha-glucosidase inhibitors
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Acarbose
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Voglibose
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Oral Antidiabetic Drugs Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class Analysis, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Abbott Laboratories
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Biocon, Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Sun Pharma Industries, Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Novo Nordisk A/S
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Pfizer
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Sanofi
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Novartis
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Latest In Healthcare Organ Preservation Solutions
Global Organ Preservation Solutions Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Organ Preservation Solutions Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Orthodontics
Global Orthodontics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Orthodontics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Oral Biologics
Global Oral Biologics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Oral Biologics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Oral Proteins and Peptides
Global Oral Proteins and Peptides Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Oral Proteins and Peptides Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...